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Infectious mononucleosis (IM) is a lymphoproliferative disorder accompanied 
by a transient  acquired immunodeficiency (1). It is characterized by an atypical 
iymphocytosis that is principally of T  cell origin.  Epstein-Barr virus (EBV) is the 
major cause of the disease and the pathogenesis of this infection has been well 
studied. The T  cell lymphocytosis is generally thought to be a response to EBV- 
infected and  -activated  B  cells.  It  includes  cytotoxic cells and  suppressor  cells 
capable of inhibiting B cell outgrowth and immunoglobulin (Ig) synthesis (2). 
In striking  contrast,  very little is known about how cytomegalovirus (CMV), 
the  second  leading  cause  of  the  disease,  generates  similar  activated  T  cell 
responses  (3) and  reversals  in  normal  helper/suppressor  T  cell  ratios  (4).  All 
current  available  evidence  indicates  that  human  CMV  does  not  replicate  in 
normal  B  lymphocytes (1).  However, some direct  or indirect  nonspecific poly- 
clonal interaction  with these cells has been implied.  Patients with CMV mono- 
nucleosis, even more than their EBV-infected counterparts, have unusually high 
frequencies of circulating  Ig-secreting  lymphocytes (5),  as well as increases  in 
antibodies that are apparently irrelevant to viral antigens (6, 7). In this paper we 
present  evidence  that  CMV  is  capable  of inducing  nonspecific  polyclonal  Ig 
synthesis and suggest that this may explain some of the serologic abnormalities 
of CMV infections. The finding is of particular  interest in view of the fact that 
hypergammaglobulinemia  has been reported in CMV-infected patients with the 
acquired immunodeficiency syndrome (AIDS) and that  in vivo polyclonal acti- 
vation of B  cells, possibly by virus,  has been suggested as contributory  to this 
facet of the disease (8). 
Materials and Methods 
Cell Preparation and Culture.  Heparinized peripheral blood was separated by flotation 
on  Lymphocyte Separation  Medium (LSM; Litton Bionettics,  Charleston,  SC). T  cells 
were depleted by rosetting with sheep erythrocytes (E; reference 9) and flotation on LSM. 
In some experiments this procedure was repeated to reduce T cell contamination to <1%. 
Leukocytes were differentiated by the ability to form E-rosettes  or stain for nonspecific 
esterases (10). Cells with neither of these properties were designated ~B cells." For plaque 
assays, 2 ×  106 cells were incubated in  12-mm × 75-ram plastic tissue culture tubes with 
virus- or mock-infected control preparations  in  a  total volume of 1.2  mi  RPMI  1640 
(Gibco Laboratories; Grand Island, NY) containing  10% heat-inactivated  fetal calf serum 
(FCS). For measurement of Ig synthesis, 2 ×  105 cells were incubated in a total volume of 
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100 •I  in 96-well round bottomed tissue culture plates with virus, control material, or 
pokeweed mitogen (PWM; Gibco). After 6 d in culture, 100 #i media were added to each 
well. On days 7, 9, 12, and 14, 100 #1 supernatant media were exchanged for fresh virus- 
free media and the Ig contents of the removed supernatants were measured. 
Virus.  EBV was obtained from spent culture media of the MCUV5 marmoset line (a 
gift  of Dr.  George  Miller,  Yale  University)  which  had  been  clarified  by  low  speed 
centrifugation. The virus was pelleted by centrifugation at 20,000 g for 90 min, resus- 
pended in 1/250 original volume of RPMI and filtered through a 0.45-#m filter. 
Towne strain  CMV,  grown  in  WI38 cells,  was  kindly donated  by Dr.  E.-S.  Huang 
(University of North Carolina) and passaged at low multiplicity of infection (m.o.i.) in 
mycoplasma-free human foreskin fibroblasts (HFF). Infected culture medium was centri- 
fuged for  10  min  at  600 g  to remove cell debris.  Control material  was  prepared by 
passaging mock-infected WI38 cells in HFF. A  fresh isolate of CMV was obtained from 
the Shands Hospital Virology Laboratory (Gainesville, FL) and passaged six times in HFF. 
CMV infectivity was determined by counting plaques 10 d after infection of monolayers 
of HFF grown in 24-well tissue culture plates. Inactivated virus was prepared by irradiation 
of 1 ml of virus, for 30 min, in a 60-mm diameter petri dish at 20 cm from a short-wave 
germicidal lamp (GTE Sylvania Inc.), after which, the virus induced no cytopathic effect 
in HFF maintained for 3 wk post infection. 
Plaque Assay.  Ig-secreting cells were enumerated in a reverse hemolytic plaque assay 
(11). Leukocytes were mixed with guinea pig serum (preadsorbed with sheep erythrocytes 
coupled to Staphylococcal Protein A  [Protein A;  Pharmacia, Piscataway, N  J]) and with 
sheep erythrocytes coupled to rabbit anti-human immunoglobulins (IgM,IgG,IgA; Cappel 
Laboratories, Cochranville, PA). The mixtures were incubated in Cunningham chambers 
for 8-10 h and plaques counted microscopically. Results were expressed as plaque-forming 
cells (PFC)/106 viable cells. 
Immunoglobulin Assays.  Immunoglobulins in culture supernatants were measured by a 
double sandwich micro-ELISA method (12), using appropriate concentrations of rabbit 
anti-human  immunoglobulins  (IgM,IgG,IgA),  anti-human  IgM,  peroxidase-conjugated 
rabbit anti-human Ig (Cappel) and the substrate hydrogen peroxide with 5-amino salicylic 
acid (Sigma Chemical Co., St. Louis, MO). 
Virus-specific Antibody.  CMV-specific antibody was measured in a solid phase radioim- 
munoassay (RIA; 13), using appropriate concentrations of  CMV-infected or mock-infected 
cell  lysates (CMV(AD169) CF antigen or control antigen;  Flow Laboratories, McLean, 
VA),  test sera  or culture supernatants,  rabbit anti-human  immunoglobulins, and  l~5I- 
labeled Protein A. Antigen was coupled to polyvinyichloride  microtiter plates and individ- 
ual wells were cut out and counted in a gamma counter. A negative sample was defined 
as one that bound no more radioactivity to CMV-infected lysates than to mock-infected 
lysates i.e., had a binding ratio of 1.5 or less. The sensitivity of this RIA was ,~200-fold 
greater than that of a standard immunofluorescence assay for CMV antibodies (14). EBV- 
specific antibody was measured by immunofluorescence (3); all but one donor (GG) was 
seropositive for EBV. 
Results 
Induction  of Plaque-forming  Cells by CMV.  Peripheral  ieukocytes from  CMV 
seronegative donors  were depleted  of T  cells and  cultured  with  EBV,  mock- 
infected control HFF preparations,  live Towne strain CMV at a  m.o.i, of 0.02, 
or irradiated Towne strain  CMV at the same concentration. After a  minimum 
of 11  d  in culture, the numbers of Ig-secreting cells were measured in a reverse 
hemolytic plaque assay (Table I).  Both live and  irradiated  CMV and live EBV 
induced  more  plaque-forming  cells  than  did  the  controls,  although  at  this 
multiplicity of infection the CMV was not as potent a stimulator as EBV. 
Immunoglobulin  Produced  in  Response to  CMV.  More  precise  analysis  of the 
response to CMV  was  made by miniaturizing cultures,  increasing the m.o.i,  to 
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TABLE  I 
Induction of Plaque-forming Cells by EBV and CMV 
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Donor 
Initial composition of culture  Days in  Plaques per 10  6 cells 





14  35  51  11  104,880  6,500*  7,940 
13  73,250  27,800*  6,500 
19  30  51  12  100,000  1,900'  2,940 
14  104,120  24,460*  360 
18  15  67  12  32,350  4,$32*  1,370 
15  23,040  3,479*  1,440 
* Live CMV. 
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FIGURE  1.  Total  Ig in cultures  from  six donors.  Cells stimulated  with:  (0--'-"'0)  irradiated 
Towne strain CMV; (O----O)  irradiated  HFF control; (O  ......  O) EBV. 
(Fig.  1).  Cells from all donors produced immunoglobulin  in response to CMV, 
although the time course of the response was variable. There was no significant 
difference in the amount produced in response to live or irradiated Towne strain 
CMV, or to the same equivalent multiplicity of irradiated low passage CMV (Fig. 
2).  However,  cells  from  some  donors  died  after  exposure  to  infectious  low 
passage virus (not shown). Approximately  Vs of the total Ig produced was IgM. 
No CMV-specific antibody could be detected by RIA in the supernatant media, 
whereas supernatants  of cultures derived from three seropositive donors had a 
binding ratio of >2. 
T Cell Dependence of the Response to CMV.  A comparison was made among the 
response of unseparated and T  cell-depleted cultures to EBV, a T-independent 
B cell activator (5, 15), PWM, a T-dependent B cell activator (15), and live CMV 
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FIGURE  2.  Comparison of Ig response to live and irradiated  CMV. (0-- -  -0)  Live Towne 
strain CMV; (H)  irradiated Towne strain CMV; (El  n) irradiated low passage CMV; 
(O-- -  -O) HFF control; (O  O) irradiated  HFF control. 
TABLE  II 
Ig (ng/ml) Produced by Unseparated and T-depleted Cultures 
Stimulant  Cell composition 
Days in culture 
7  9  12  14 
PWM  Unseparated  435  768  974  307 
T-Depleted*  47  19  11  4 
EBV  Unseparated  122  211  154  32 
T-Depleted  176  428  513  215 
DMV  Unseparated  107  180  433  158 
T-Depleted  237  397  618  380 
HFF Control  Unseparated  142  69  171  57 
T-Depleted  71  11  29  21 
* Cultures contained <0.5% T  cells. 
markedly reduced in cultures depleted of T  cells. In contrast,  the responses to 
EBV and CMV were increased. 
Discussion 
The  work in  this paper  indicates that  CMV can induce human  lymphocytes 
from  CMV  seronegative  donors  to produce immunoglobulin.  None of the  Ig 
produced was detectably CMV-specific; this was in contrast to the small amount 
of CMV-specific antibody that was produced by leukocytes cultured from CMV 
seropositive donors.  At least Vs of it was IgM. The amounts produced were of 
the same order of magnitude as those induced by EBV or PWM. We conclude 
therefore that the response to CMV is not an amplified anamnastic response, but 
rather a true nonspecific polyclonal activation of B cells. 
The immunoglobulin response to CMV, unlike that to EBV (5) is not abrogated 
by irradiation  of virus.  Neither  is it limited to laboratory strains of virus.  The 
contrast  in  the effects of T  cell depletion clearly distinguishes  the response to 
PWM and  HFF controls from that  to EBV and CMV.  PWM is a  T-dependent 
mitogen and the reduction  in the response of T-depleted cultures  to the  HFF 
control,  suggests  that  this  "background"  level  of Ig  synthesis  results  from  a 
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to reduce the response to CMV suggests that CMV, like EBV, is a T-independent 
polyclonal B cell activator. Although the amounts of Ig produced by T-depleted 
cultures  increased  with  the  numbers  of B  cells present,  the  increase  was  not 
directly proportional for either CMV or EBV. This may reflect a deterioration 
in culture conditions (17); certainly, the exchange and effective dilution of culture 
medium  four times during  the assay period  may have had  deleterious effects. 
However,  it  is  also  possible that  changes  in  B  cell/monocyte ratios,  that  are 
attendant on T  cell depletion, may have profoundly influenced virus/leukocyte 
interactions (16,  18). 
Hypergammaglobulinemia,  cryoglobulinemia,  and  autoantibody  production 
are features of CMV-IM and post-perfusion syndrome (6, 7). The ability of CMV 
to stimulate polyclonal Ig synthesis provides a provocative explanation for these 
phenomena  and  identifies what  may be a  pathogenic  event common to CMV 
and EBV mononucleosis.  It merits further study as a  possible indirect cause of 
the  changes  in  T  cell  function  in  mononucleosis.  In  addition,  in  view of the 
association of CMV with AIDS (19), it might be investigated as a contributor to 
the abnormalities of B cell function that may occur in this syndrome (8). 
Summary 
Human cytomegalovirus is shown to be a nonspecific polyclonal B cell activator. 
The B cell response is independent of virus replication and requires little, if any, 
T  cell help. 
We thank  Ann  McNicoi  for excellent technical  help  and  Herb Houck for providing 
fibroblast cultures. 
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